The Effect of Different Diets on Arterial Stiffness in Obese Patients on Semaglutide
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-49
SponsorAmerican University of Beirut Medical Center
About this trial
In patients initiating Semaglutide for weight management, the objective is to compare the effect of the Mediterranean diet and the high protein/low carbohydrate (HP/LC) diet CV parameters, namely arterial stiffness, measured by carotid-femoral pulse wave velocity (cfPWV), and visceral adipose tissue, in addition to other metabolic indicators.
Eligibility criteria
Qualifiers
Men and premenopausal women, 18-49 years, with obesity defined as BMI ≥ 30 kg/m2
Upon the initiation of Semaglutide (within the first 1-4 weeks) for medical weight management, for clinical purposes, as advised by the primary physician
Able to commit for a 6-month trial visits
Disqualifiers
Pregnant women
Patients who are taking or have taken other weight reducing drug therapies in the previous 6 months
Patients who have undergone metabolic weight loss surgery
Patients known to have diabetes (HbA1c ≥6.5% at screening)
Trial design
Treatments tested in this trial
- Dietary Intervention Med Diet
- Dietary Intervention HP/LC Diet
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov